Histone modification landscape

Show results for

Genomics (547)
Unknown (253)
Transcriptomics (130)
Proteomics (50)
Other (26)
Methylation profiling (15)

Organisms

Homo sapiens (167)
Mus musculus (142)
Arabidopsis thaliana (11)
Rattus norvegicus (10)
Drosophila melanogaster (5)
Bos taurus (4)
Oryza sativa (4)
Saccharomyces cerevisiae (3)
Fusarium graminearum PH-1 (3)
Brassica napus (3)
Solanum lycopersicum (3)
Caenorhabditis elegans (3)
Schizosaccharomyces pombe (2)
Plasmodium falciparum (2)
Dianthus caryophyllus (2)
Populus (2)
Saccharum officinarum (2)
Rhizopus microsporus (2)
Solanum tuberosum (2)
Citrus sinensis (2)
Triticum aestivum (2)
Glycine max (2)
Zea mays (2)
Danio rerio (2)
Sus scrofa (2)
Eucalyptus grandis (1)
Escherichia coli str. K-12 substr. DH10B (1)
Plasmodium berghei (1)
Oryza sativa Indica Group (1)
Cricetulus griseus (1)

Organisms

Homo sapiens (150)
Mus musculus (120)
Rattus norvegicus (9)
Bos taurus (8)
Arabidopsis thaliana (7)
Drosophila melanogaster (5)
Caenorhabditis elegans (3)
Saccharomyces cerevisiae (3)
Rhizopus microsporus (2)
Schizosaccharomyces pombe (2)
Sus scrofa (2)
Danio rerio (2)
Fusarium graminearum PH-1 (1)
Drosophila miranda (1)
Brassica napus (1)
Saccharomyces cerevisiae BY4741 (1)
Solanum lycopersicum (1)
Oryza sativa (1)
Gallus gallus (1)

Repository

ENA (364)
geo (260)
biostudies-arrayexpress (92)
pride (34)
MassIVE (11)
iProX (3)
EGA (2)
jPOST (1)
PanoramaPublic (1)

Tissue

Cell culture (13)
Embryo (4)
Embryonic stem cell (3)
Permanent cell line cell (2)
Plant cell (2)
Binucleate (1)
Brain (1)
Breast (1)
Burkitt lymphoma cell line (1)
Cell suspension culture (1)
Corolla (1)
Early embryonic cell (1)
Embryo stage (1)
Glial cell (1)
Head and neck cancer cell (1)
Heart (1)
Hepatocyte (1)
Kidney (1)
Leaf (1)
Liver (1)
Lymphocyte of B lineage (1)
Neuronal stem cell (1)
Prostate cancer cell line (1)
Seedling (1)
Trophozoite (1)
Whole body (1)
Whole plant (1)

Disease

Chronic myeloid leukemia (3)
Burkitt lymphoma (1)
Diffuse midline glioma (1)
Endocervical adenocarcinoma (1)
Epstein-Barr virus-related Burkitts lymphoma (1)
Giardiasis (1)
Parkinson's disease (1)

Technology Type

Mass Spectrometry (34)
Bottom-up proteomics (13)
Shotgun proteomics (13)
Data-dependent acquisition (6)
Affinity purification coupled with mass spectrometry proteomics (4)
SRM/MRM (2)
Data-independent acquisition (1)
Gel-based experiment (1)
Mass spectrometry imaging (1)

Instrument Platform

LTQ Orbitrap (7)
Illumina Genome Analyzer II (2)
Illumina HiSeq 2500 (2)
Illumina HiSeq 2000 (2)
LTQ Orbitrap Velos (2)
Illumina Genome Analyzer IIx (1)
Illumina NovaSeq 6000 (1)
Orbitrap Fusion Lumos (1)
Q Exactive (1)

Publication Date

2025 (60)
2023 (48)
2015 (40)
2026 (37)
2016 (32)
2024 (25)
2020 (24)
2014 (22)
2021 (19)
2013 (17)
2022 (16)
2011 (12)
2019 (12)
2010 (10)
2018 (10)
2012 (8)
2017 (4)
2006 (1)
2005 (1)
2007 (1)

First Public Date

2025 (57)
2023 (53)
2026 (47)
2024 (42)
2016 (26)
2022 (23)
2021 (22)
2020 (21)
2018 (15)
2019 (14)
2013 (14)
2015 (13)
2014 (13)
2017 (4)

Classification

fungi (3)

Modification

N6 (4)
2x(15)N labeled L-lysine (1)
4x(15)N labeled L-arginine (1)
N6-dimethyl-L-lysine (1)

Study type

ChIP-seq (42)
RNA-seq of coding RNA (15)
Transcription profiling by array (14)
Methylation profiling by high throughput sequencing (8)
ChIP-chip by array (4)
RNA-seq of non coding RNA (3)
Unknown experiment type (1)
ChIP-chip by tiling array (1)
ATAC-seq (1)
Other (1)
Methylation profiling by array (1)
RNA-seq of total RNA (1)

Release Date

2015 (36)
2025 (35)
2023 (32)
2014 (27)
2016 (25)
2022 (24)
2021 (21)
2020 (21)
2024 (21)
2013 (18)
2011 (18)
2010 (12)
2017 (11)
2019 (10)
2018 (10)
2012 (9)
2026 (6)
2006 (3)
2009 (2)
2005 (1)
2008 (1)
2007 (1)
2003 (1)

Lab affiliation

CECAD Cluster of Excellence, University of Cologne (2)
Transcription and Disease Laboratory, Molecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, Karnataka, India (2)
1 Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA. 2 Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710, USA 3 Duke Cancer Institute, Duke University School of Medicine, Durham, NC 27710, USA 4 Department of Pathology, Duke University School of Medicine, Durham, NC 27710, USA (1)
1 Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry,Germany. 2 NNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (1)
1 Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia Department of Veterinary Biosciences, Melbourne Veterinary School, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, VIC, Australia (1)
Assistant Professor Department of Medicine, Division of Endocrinology, Metabolism, and Nutrition Department of Pharmacology and Cancer Biology Duke University Medical Center (1)
Babraham Institute (1)
Biomedical Center, Chromatin Proteomics Group, Department of Molecular Biology, Faculty of Medicine, Ludwig-Maximilians-Universität München, Großhaderner Strasse 9, 82152 Planegg-Martinsried, Germany. (1)
Center for RNA Research, Institute for Basic Science, Seoul 08826, S. Korea School of Biological Sciences, Seoul National University, Seoul 08826, S. Korea (1)
Chinese Academy of Sciences Shanghai Institute of Materia Medica (1)
Chromosome dynamics and genome stability, Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, Feodor-Lynen-Strasse 21, 81377 München, Germany (1)
Department of Biochemistry and Molecular Biology and VILLUM Center for Bioanalytical Sciences, University of Southern Denmark, Campusvej 55, DK - 5230 Odense M, Denmark (1)
Department of Experimental Oncology, IEO, European Institute of Oncology IRCSS, 20139, Milan, Italy (1)
Director of Carnegie MS facility (1)
Epigenetics Program, Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA (1)
European Institute of Oncology, Milan, Italy (1)
Fujian Provincial Key Laboratory of Plant Functional Biology, Fujian Agriculture and Forestry University, Fuzhou 350002, China (1)
Gregor Mendel Institute of the Austrian Academy of Sciences (1)
Institute of Epigenetics and Stem Cells, Helmholtz ZentrumMünchen, Feodor-Lynen- Strasse 21, 81377 München, Germany (1)
Institute of Genetics and Cancer The University of Edinburgh Western General Hospital Crewe Road South Edinburgh EH4 2XU (1)
Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500 Bellinzona, Switzerland (1)
Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, L69 3BX, United Kingdom (1)
Max-Planck Institute of Biochemistry, Laboratory of Chromatin Biology, Martinsried, Germany (1)
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen (1)
ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, B-9000 Ghent, Belgium (1)
Proteomics program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark (1)
Radboud University/Radboud UMC, Faculty of Science, Department of Molecular Biology, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands (1)
South China Agricultural University (1)
State Key Laboratory of Reproductive Medicine, Nanjing Medical University (1)
U o Edinburgh (1)

Previous page
1 / 103
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 103
Next page

Sort by:

Relevance

Page size

A strategy to characterize the global histone PTM landscape within tissues of non-model organisms

Histone post-translational modifications (PTMs) are epigenetic marks that play a critical role in the expression and maintenance of DNA, but they remain largely uninvestigated in non-model organisms due to technical challenges. To begin alleviating this issue, we developed a workflow for histone PTM...

ORGANISM(S): Oreochromis Mossambicus

2024-02-29 | PXD040536 | panorama

DNA Methylation shapes histone modification landscape for transcription regulation in Arabidopsis [WGBS]

PRJNA762579 | ENA

DNA Methylation shapes histone modification landscape for transcription regulation in Arabidopsis [ChIP-Seq]

PRJNA762490 | ENA

DNA Methylation shapes histone modification landscape for transcription regulation in Arabidopsis [RNA-Seq]

PRJNA762574 | ENA

Loss of Foxp3-driven epigenetic modification leads to regulatory T cell insufficiency

Regulatory T cells (Tregs) are responsible for limiting autoimmunity and chronic inflammation. Foxp3 is a transcription factor that acts as a master regulator of Treg development and function. A serendipitous observation led to the realization that a well-characterized Foxp3gfp reporter mouse, whic...

ORGANISM(S): Mus musculus

2012-12-07 | E-GEOD-35164 | biostudies-arrayexpress

Breaking Boundaries in Histone Modification MS-based Detection: A Tailored Search Strategy for Unrestricted identification of novel epigenetic marks

Histone post-translational modifications (PTMs) are crucial for gene expression regulation and DNA maintenance, and their aberrations are linked to multiple diseases, like cancer. While functions related to lysine acetylation and methylation have been well-studied, recent studies have uncovered addi...

ORGANISM(S): Homo sapiens (Human)

2025-11-11 | PXD061934 | Pride

Histone modifications in Plasmodium falciparum at 12 hours post-invasion

Synchronized Plasmodium falciparum-infected human blood cultures were harvested at seven time points along the asexual intra-erythrocytic parasite life cycle: 0 hours post-invasion, 6 hpi, 12 hpi, 18 hpi, 24 hpi, 30 hpi and 36 hpi. Plasmodium histones were extracted using the standard hydrochloric ...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606) Plasmodium Falciparum 3d7 (ncbitaxon:36329)

2015-08-12 | MSV000079227 | MassIVE

Histone modifications in Plasmodium falciparum at 24 hours post-invasion

ORGANISM(S): Homo Sapiens (ncbitaxon:9606) Plasmodium Falciparum 3d7 (ncbitaxon:36329)

2015-08-12 | MSV000079229 | MassIVE

Histone modifications in Plasmodium falciparum at 6 hours post-invasion

ORGANISM(S): Homo Sapiens (ncbitaxon:9606) Plasmodium Falciparum 3d7 (ncbitaxon:36329)

2015-08-12 | MSV000079226 | MassIVE

Histone modifications in Plasmodium falciparum at 30 hours post-invasion

ORGANISM(S): Homo Sapiens (ncbitaxon:9606) Plasmodium Falciparum 3d7 (ncbitaxon:36329)

2015-08-12 | MSV000079230 | MassIVE

Previous page
1 / 103
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 103
Next page

Sort by:

Relevance

Page size

1021 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

First Public Date

Classification

Modification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets